GRI Genes Roundtable - Dec 2021
Share This Post
GRI Genes Research Roundtable Summary
CureGRIN Foundation hosted our eleventh GRI Genes Roundtable on Thursday, December 2, 2021. Our goal is to promote collaboration so that we can accelerate the path to treatments and cures for GRI Disorders.
We brought together researchers and clinicians studying GRI Disorders, GRIN genes, GRIA genes, GRIK genes, NMDA receptors, and other ionotropic receptors (AMPARs, kainate receptors, and delta receptors) to discuss and exchange ideas.
We asked Connor Williams-McArthur to share his sibling story about his brother Bryson with a variant in GRIN1. We also heard three researcher presentations from Dr. Yukiko Goda, Jenna Gale, and Dr. Joseph Anderson. This document summarizes these presentations.
Our next GRI Genes Research Roundtable is scheduled for: Thursday, February 3, 2022.
If you are a GRIN / NMDAR researcher and/or a GRIA genes/AMPAR researcher or clinician, please reach out to meagan@curegrin.org to be added to the next meeting invitation.
Read more Posts
Radiprodil reduces seizures in GRIN (gain-of-function) patients by a median of 86% in first-ever commercial clinical trial for GRI Disorders
The potential treatment also led to clinical improvements in other symptoms, and was well tolerated from a safety perspective.
How I Became a GRIN Disorder Champion
Share This Post Share on facebook Share on linkedin Share on twitter Share on email Searching and Finding at the CFERV Conference on GRIN Variants
